Page last updated: 2024-09-05

nanaomycin e and imiquimod

nanaomycin e has been researched along with imiquimod in 1 studies

*Imiquimod: A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS. [MeSH]

*Imiquimod: A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS. [MeSH]

Compound Research Comparison

Studies
(nanaomycin e)
Trials
(nanaomycin e)
Recent Studies (post-2010)
(nanaomycin e)
Studies
(imiquimod)
Trials
(imiquimod)
Recent Studies (post-2010) (imiquimod)
6013,2642841,963

Protein Interaction Comparison

ProteinTaxonomynanaomycin e (IC50)imiquimod (IC50)
Histamine H2 receptorHomo sapiens (human)1.506
Alpha-1D adrenergic receptorHomo sapiens (human)2.621
Adenosine receptor A2aHomo sapiens (human)5.32
7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)0.646

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Funatsu, T; Harada, Y; Ikoma, K; Matsui, Y; Misawa, T; Nakayama, A; Nishida, S; Noguchi, Y; Pan, Y; Saitoh, T; Shirasaki, Y; Sunazuka, T; Takahama, M; Takemura, N; Taura, M1

Other Studies

1 other study(ies) available for nanaomycin e and imiquimod

ArticleYear
Nanaomycin E inhibits NLRP3 inflammasome activation by preventing mitochondrial dysfunction.
    International immunology, 2022, 09-09, Volume: 34, Issue:10

    Topics: Caspase 1; Imiquimod; Inflammasomes; Interleukin-1beta; Mitochondria; Naphthoquinones; NLR Family, Pyrin Domain-Containing 3 Protein

2022